204 related articles for article (PubMed ID: 22546234)
1. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
[TBL] [Abstract][Full Text] [Related]
2. [Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats].
Qiang GF; Zhang L; Xuan Q; Yang XY; Shi LL; Zhang HA; Chen BN; Du GH
Yao Xue Xue Bao; 2010 Jun; 45(6):801-6. PubMed ID: 20939194
[TBL] [Abstract][Full Text] [Related]
3. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
4. Salvianolic Acid a prevents the pathological progression of hepatic fibrosis in high-fat diet-fed and streptozotocin-induced diabetic rats.
Qiang G; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Zhang L; Du G
Am J Chin Med; 2014; 42(5):1183-98. PubMed ID: 25183303
[TBL] [Abstract][Full Text] [Related]
5. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
6. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
Gong ZJ; Song SL; Huang YQ; Ruan P
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
8. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
9. [The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].
Shen FJ; Zhu YK; Jia JD; Ma H; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):605-8. PubMed ID: 15504291
[TBL] [Abstract][Full Text] [Related]
10. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
13. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
[TBL] [Abstract][Full Text] [Related]
14. Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion.
Wu B; Lin R; Dai R; Chen C; Wu H; Hong M
Eur J Pharmacol; 2013 Apr; 705(1-3):140-7. PubMed ID: 23499691
[TBL] [Abstract][Full Text] [Related]
15. [Effect of antioxidant on hepatic stellate cell proliferation and apoptosis during recovery from liver fibrosis].
Shen XH; Cheng WF; Li XH; Xie LM; Sun J; Li F; Ma L
Wei Sheng Yan Jiu; 2005 Mar; 34(2):194-6. PubMed ID: 15952662
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
17. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ
Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
[TBL] [Abstract][Full Text] [Related]
19. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
Yang HX; Yi YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
[TBL] [Abstract][Full Text] [Related]
20. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]